Receptors, Adrenergic, beta-2
"Receptors, Adrenergic, beta-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-2 receptors are more sensitive to EPINEPHRINE than to NOREPINEPHRINE and have a high affinity for the agonist TERBUTALINE. They are widespread, with clinically important roles in SKELETAL MUSCLE; LIVER; and vascular, bronchial, gastrointestinal, and genitourinary SMOOTH MUSCLE.
|Receptors, Adrenergic, beta-2
- Receptors, Adrenergic, beta-2
- beta 2 Adrenergic Receptors
- Receptor, Adrenergic, beta-2
- Receptors, beta-2 Adrenergic
- Receptors, beta 2 Adrenergic
- Adrenergic beta-2 Receptors
- Adrenergic beta 2 Receptors
- Receptors, Adrenergic beta-2
- beta-2 Receptors, Adrenergic
- Adrenergic Receptor, beta-2
- Adrenergic Receptor, beta 2
- Receptor, beta-2 Adrenergic
- beta-2 Adrenergic Receptor
- beta-2 Adrenergic Receptors
- Adrenergic Receptors, beta-2
Below are MeSH descriptors whose meaning is more general than "Receptors, Adrenergic, beta-2".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Adrenergic [D12.776.543.750.670.300.300]
- Receptors, Adrenergic, beta [D12.776.543.750.670.300.300.340]
- Receptors, Adrenergic, beta-2 [D12.776.543.750.670.300.300.340.200]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Adrenergic [D12.776.543.750.695.150.300]
- Receptors, Adrenergic, beta [D12.776.543.750.695.150.300.340]
- Receptors, Adrenergic, beta-2 [D12.776.543.750.695.150.300.340.725]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Adrenergic [D12.776.543.750.720.330.300]
- Receptors, Adrenergic, beta [D12.776.543.750.720.330.300.340]
- Receptors, Adrenergic, beta-2 [D12.776.543.750.720.330.300.340.200]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Adrenergic, beta-2".
This graph shows the total number of publications written about "Receptors, Adrenergic, beta-2" by people in this website by year, and whether "Receptors, Adrenergic, beta-2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Adrenergic, beta-2" by people in Profiles.
Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017 Jul 01; 19(7):1211-1219.
Activating autoantibodies to the ß1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism. Endocrine. 2015 Jun; 49(2):457-63.
Atrial tachyarrhythmias induced by the combined effects of ß1/2-adrenergic autoantibodies and thyroid hormone in the rabbit. J Cardiovasc Transl Res. 2014 Aug; 7(6):581-9.
Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014 Feb 26; 3(1):e000755.
Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. J Biol Chem. 2013 Oct 18; 288(42):30734-30741.
Atrial tachycardia provoked in the presence of activating autoantibodies to ß2-adrenergic receptor in the rabbit. Heart Rhythm. 2013 Mar; 10(3):436-41.
ß2 Adrenoceptor signaling-induced muscle hypertrophy from blood flow restriction: is there evidence? Horm Metab Res. 2012 Jun; 44(7):489-93.
Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012 Feb; 59(2):402-8.
miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun. 2011 Mar 25; 406(4):518-23.
Opposing cardiac effects of autoantibody activation of ß-adrenergic and M2 muscarinic receptors in cardiac-related diseases. Int J Cardiol. 2011 May 05; 148(3):331-6.